Cerevel Therapeutics (CERE)
(Delayed Data from NSDQ)
$42.47 USD
+0.40 (0.95%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $42.44 -0.03 (-0.07%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth D Momentum F VGM
Earnings News For CERE
-
Cerevel Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
-
Cerevel Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
-
Cerevel Therapeutics Appoints Ron Renaud as President and Chief Executive Officer and Reports First Quarter 2023 Financial Results
-
Cerevel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
-
Cerevel Therapeutics Reports Third Quarter 2022 Financial Results and Business Updates